MedSafetyWeek 2022 - Reporting suspected adverse drug reactions helps improve drug safety

Drug authorities around the world are reminding people of the importance of reporting suspected adverse drug reactions in a joint campaign called MedSafetyWeek. This year's campaign focuses on the important role of healthcare professionals and patients who contribute to the safety of medicines by reporting a suspected adverse reaction.

The "MedSafetyWeek" campaign will take place this year from Nov. 7 to Nov. 13, 2022, for the seventh consecutive year. A total of 82 countries worldwide are participating in the campaign.